Abstract:RNA‐binding protein QKI (also known as Quaking) belongs to hnRNP K‐homology (KH)‐domain protein family and is implicated a novel regulator in pre‐RNA splicing. As previously shown, the QKI homolog how potentially regulates heart lumen formation and function in fruit fly. However, QKI ’s function in mammalian heart development is largely unknown. We found that Qki specifically expressed in mouse developing hearts as early as E7.0 and this high‐level expression was maintained in the hearts to adulthood. Consistent with this finding, by using human embryonic stem cells (hESCs)‐cardiomyocyte differentiation system, QKI expression was found up‐regulated at Day 6, a critical time frame that cardiogenic progenitor transition into early cardiomyocytes. To determine the biological function of QKI in cardiogenesis, we generated hESCs QKIdef by using CRISPR/Cas9 gene editing technology and analyzed the physiological impact of QKI ‐deficiency to cardiomyocyte differentiation and maturation. As expected, we did not find defect in pluripotency in hESCs QKIdef , but the contractile function was dramatically reduced in hESCs QKIdef ‐derived cardiomyocytes. Based on scRNA‐seq and clustering analyses, there was no significant difference in the distribution of the clusters when compared hESCs QKIdef ‐cardiomyocyte group to normal control group, suggesting that the cardiomyocyte differentiation was largely unaffected in hESCs QKIdef . However, scRNA‐seq demonstrated a handful of genes encoding sarcomere proteins were significantly altered in cardiomyocyte clusters, which included ACTN2, ACTA1, MYH7, and MYL2, etc., indicating a significant defect in cardiomyocyte maturation. Bulk RNA‐seq data not only further confirmed this notion, but also provided additional depth for detailed analysis on the QKI ‐mediated pre‐RNA splicing events. In conjunction with QKI ‐binding motif search and RNA immunoprecipitation (RIP) analysis, we were able to demonstrate that QKI was a key pre‐RNA splicing regulator for sets of genes involved in cardiac myofibrillogenesis and cardiac excitation‐contraction (E‐C) coupling, which ultimately impacted on cardiomyocyte maturation and function. Additional analysis of cardiac developmental defects in Qki bgeo mutant mice further validated that QKI was an indispensable splicing regulator in cardiovascular development. Our results not only revealed a novel mechanism by which QKI regulates pre‐mRNA splicing in cardiogenesis, but also implied that QKI was likely involved in the pathogenesis of certain forms of congenital heart defects and cardiomyopathies. Support or Funding Information This work was supported in part by National Institute of Health P01HL134599

Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer

QUAKING KH domain proteins as regulators of glial cell fate and myelination

Rescuing qkV dysmyelination by a single isoform of the selective RNA-binding protein QKI

The Quakingviable Mutation Affects Qki Mrna Expression Specifically in Myelin-Producing Cells of the Nervous System

Gene inactivation of Na+/H+ exchanger isoform 1 attenuates apoptosis and mitochondrial damage following transient focal cerebral ischemia.

Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1

RNA-Binding Protein <it>QKI</it> is a critical pre-RNA splicing regulator for cardiac development and function

Qki5 safeguards spinal motor neuron function by defining the motor neuron-specific transcriptome via pre-mRNA processing

Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia

The RNA binding protein Quaking represses splicing of the Fibronectin EDA exon and downregulates the interferon response

Target RNA motif and target mRNAs of the Quaking STAR protein

Remarkable sequence conservation of transcripts encoding amphibian and mammalian homologues of quaking, a KH domain RNA-binding protein

QKI is a critical pre-mRNA alternative splicing regulator of cardiac myofibrillogenesis and contractile function

QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism

QKI Shuttles Internal M7g-Modified Transcripts into Stress Granules and Modulates Mrna Metabolism

Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo.

Distinct Molecular Mechanisms Lead to Diminished Myelin Basic Protein and 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase in Qk(v) Dysmyelination.

Epco-17. Carm1 Methylates Glioblastoma Tumor Suppressor Quaking To Regulate Its Transcriptional Coactivator Function

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing

Defining the breakpoints of the quaking(viable) mouse mutation reveals a duplication from a Parkin intron